START- Madrid

Madrid 28050

2 studies enrolling now · 7 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumors, Breast Cancer, Colorectal Cancer, Lymphoma, Melanoma, Non-Small Cell Lung Cancer (NSCLC), Non-small Cell Lung Cancer, PI3K Gene Mutation, Pancreatic Ductal Adenocarcinoma, Select Advanced Solid Tumors, Solid Tumor

Studies at this site

• Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors — Recruiting now
• First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors — Recruiting now
• First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer — Running, not enrolling
• A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors — Running, not enrolling
• PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors — Stopped early
• A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer — Stopped early
• Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 — Stopped early